CLARKE JOHN K 4
4 · aTYR PHARMA INC · Filed Apr 29, 2021
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
CLARKE JOHN K
DirectorOther
Transactions
- Award
Stock Option (right to buy)
2021-04-28+1,428→ 1,428 totalExercise: $4.21Exp: 2031-04-28→ Common Stock (1,428 underlying)
Footnotes (1)
- [F1]The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) April 28, 2022 or (ii) the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.